Holen Sie sich die Stockscreener-App
4.25
3.16%
0.13
Schlusskurs vom Vortag:
$4.12
Offen:
$4.21
24-Stunden-Volumen:
2,505
Relative Volume:
0.28
Marktkapitalisierung:
$6.00M
Einnahmen:
$5.67M
Nettoeinkommen (Verlust:
$-13.98M
KGV:
-0.3008
EPS:
-14.13
Netto-Cashflow:
$-15.30M
1W Leistung:
-1.16%
1M Leistung:
+34.92%
6M Leistung:
+10.10%
1J Leistung:
+58.58%
1-Tages-Spanne:
$3.948
$4.2619
1-Wochen-Bereich:
$3.50
$4.86
52-Wochen-Spanne:
$2.40
$10.31
Arcadia Biosciences Inc Stock (RKDA) Company Profile
Firmenname
Arcadia Biosciences Inc
Sektor
Branche
Telefon
530-756-7077
Adresse
202 COUSTEAU PLACE, DAVIS, CA
Vergleichen Sie RKDA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RKDA
Arcadia Biosciences Inc
|
4.25 | 6.00M | 5.67M | -13.98M | -15.30M | -14.13 |
|
KHC
Kraft Heinz Co
|
27.20 | 33.61B | 25.43B | 2.66B | 3.03B | 2.19 |
|
GIS
General Mills Inc
|
53.40 | 29.88B | 19.64B | 2.56B | 2.48B | 4.55 |
|
K
Kellanova
|
81.82 | 28.64B | 12.63B | 1.38B | 863.00M | 3.96 |
|
MKC
Mccormick Co Inc
|
73.73 | 20.04B | 6.68B | 792.60M | 774.40M | 2.94 |
|
HRL
Hormel Foods Corp
|
29.20 | 16.03B | 11.91B | 756.75M | 890.57M | 1.37 |
Arcadia Biosciences Inc Stock (RKDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-08-17 | Bestätigt | H.C. Wainwright | Buy |
| 2017-05-12 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2015-06-09 | Eingeleitet | Credit Suisse | Outperform |
| 2015-06-09 | Eingeleitet | Piper Jaffray | Overweight |
Arcadia Biosciences Inc Aktie (RKDA) Neueste Nachrichten
SEC Form 4 filed by Chief Financial Officer Kawakami Mark - Quantisnow
SEC Form 4 filed by Chief Executive Officer Schaefer Thomas J. - Quantisnow
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q1 2025 Earnings Call Transcript - Insider Monkey
Arcadia Biosciences (NASDAQ:RKDA) Now Covered by Analysts at StockNews.com - Defense World
Arcadia Biosciences Reports Strong Growth Amid Challenges - TipRanks
Arcadia Biosciences: Q1 Earnings Snapshot - New Haven Register
Arcadia Biosciences Inc (RKDA) Q1 2025 Earnings Call Highlights: Strong Zola Sales and ... - Yahoo Finance
Arcadia Biosciences Inc (RKDA) Q1 2025 Earnings Call Highlights: Strong Zola Sales and Strategic Moves Amid Challenges - GuruFocus
Earnings call transcript: Arcadia Biosciences sees Q1 2025 revenue rise 22% - Investing.com
Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights - GlobeNewswire
Arcadia Biosciences Q1 Earnings Preview - MSN
Arcadia Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Arcadia Climbs on Q1 Figures - Baystreet.ca
ARCADIA BIOSCIENCES Earnings Results: $RKDA Reports Quarterly Earnings - Nasdaq
Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights | RKDA Stock News - GuruFocus
Arcadia Biosciences, Inc. SEC 10-Q Report - TradingView
Arcadia Biosciences reports Q1 revenue $1.2M vs $987k last yea - TipRanks
Arcadia Biosciences Inc (RKDA) Q1 2025 Earnings Report Preview: What To Expect - GuruFocus
Geode Capital Management LLC Takes $73,000 Position in Arcadia Biosciences, Inc. (NASDAQ:RKDA) - Defense World
Halper Sadeh LLP, Arcadia Biosciences, Inc., The Interpublic Group of Companies, Inc., Omnicom Group Inc., Enterprise Bancorp, Inc. - Olean Times Herald
Arcadia Biosciences (NASDAQ:RKDA) Earns Sell Rating from Analysts at StockNews.com - Defense World
Arcadia Biosciences (RKDA) Announces Date of First Quarter 2025 - GuruFocus
Arcadia Biosciences, Inc. Announces Q1 2025 Financial Results Release and Conference Call Schedule - Nasdaq
Arcadia Biosciences (RKDA) Announces Date of First Quarter - GlobeNewswire
Mark Your Calendar: Arcadia Biosciences to Reveal Q1 2025 Financial Performance on May 8 - Stock Titan
Press Release Distribution & PR Platform - ACCESS Newswire
Arcadia Biosciences (NASDAQ:RKDA) Now Covered by StockNews.com - Defense World
Arcadia Biosciences (NASDAQ:RKDA) Coverage Initiated by Analysts at StockNews.com - The AM Reporter
Arcadia Biosciences regains IP rights, amends agreement By Investing.com - Investing.com India
Arcadia Biosciences regains IP rights, amends agreement - Investing.com
Arcadia Biosciences IncEnters Agreement To Transfer Patents And Rights With A Third Party- SEC Filing - MarketScreener
Head-To-Head Contrast: Lendway (NASDAQ:LDWY) versus Arcadia Biosciences (NASDAQ:RKDA) - The AM Reporter
Arcadia Biosciences (NASDAQ:RKDA) vs. Lendway (NASDAQ:LDWY) Critical Analysis - Defense World
Arcadia Biosciences Inc. (RKDA) reports earnings - qz.com
Arcadia Biosciences outlines 2025 growth potential for Zola after 46% sales increase in 2024 - MSN
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q4 2024 Earnings Call Transcript - Insider Monkey
Arcadia Biosciences CEO Thomas Schaefer buys $1,743 in stock - MSN
Arcadia Biosciences Earnings Call Highlights Zola Growth - TipRanks
Arcadia Biosciences Inc (RKDA) Q4 2024 Earnings Report Preview: What To Look For - GuruFocus.com
Arcadia Biosciences Inc (RKDA) Q4 2024 Earnings Call Highlights: Strong Zola Sales Propel ... - Yahoo Finance
Arcadia Biosciences Reports Strong Revenue Growth in 2024 - TipRanks
Earnings call transcript: Arcadia Biosciences Q4 2024 sees revenue growth By Investing.com - Investing.com Canada
Arcadia Biosciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits - Quantisnow
Finanzdaten der Arcadia Biosciences Inc-Aktie (RKDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Arcadia Biosciences Inc-Aktie (RKDA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Schaefer Thomas J. | Chief Executive Officer |
Feb 03 '25 |
Buy |
2.49 |
700 |
1,743 |
2,819 |
| Kawakami Mark | Chief Financial Officer |
Aug 01 '24 |
Buy |
2.06 |
700 |
1,442 |
1,981 |
| Schaefer Thomas J. | Chief Executive Officer |
Aug 01 '24 |
Buy |
2.06 |
700 |
1,442 |
2,119 |
1.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):